0001209191-20-030482.txt : 20200519
0001209191-20-030482.hdr.sgml : 20200519
20200519162944
ACCESSION NUMBER: 0001209191-20-030482
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200515
FILED AS OF DATE: 20200519
DATE AS OF CHANGE: 20200519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20894034
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-15
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Patient Officer
Common Stock
2020-05-15
4
S
0
1
274.67
D
35160
D
Common Stock
2020-05-15
4
S
0
3
276.21
D
35157
D
Common Stock
2020-05-15
4
S
0
1
278.42
D
35156
D
Common Stock
2020-05-15
4
S
0
10
280.34
D
35146
D
Common Stock
2020-05-15
4
S
0
2
281.65
D
35144
D
Common Stock
2020-05-15
4
S
0
5
283.01
D
35139
D
Common Stock
2020-05-15
4
S
0
6
284.95
D
35133
D
Common Stock
2020-05-15
4
S
0
11
286.63
D
35122
D
Common Stock
2020-05-15
4
S
0
13
287.65
D
35109
D
Common Stock
2020-05-15
4
S
0
6
288.36
D
35103
D
Common Stock
882
I
401(k)
Common Stock
14002
I
GRAT
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $276.21 (range $275.87 to $276.44).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $280.34 (range $279.91 to $280.73).
Open market sales reported on this line occurred at a weighted average price of $281.65 (range $281.24 to $282.06).
Open market sales reported on this line occurred at a weighted average price of $283.01 (range $282.71 to $283.40).
Open market sales reported on this line occurred at a weighted average price of $284.95 (range $284.37 to $285.35).
Open market sales reported on this line occurred at a weighted average price of $286.63 (range $286.14 to $287.12).
Open market sales reported on this line occurred at a weighted average price of $287.65 (range $287.22 to $288.19).
Open market sales reported on this line occurred at a weighted average price of $288.36 (range $288.23 to $288.47).
/s/ Sabrina Yohai, Attorney-in-Fact
2020-05-19